Dr. Lisa Shing-E Lu Wang, MD

Dr. Wang practices at PIH Health Whittier Hospital in Whittier, California, part of PIH Health.

Dr. Wang's NPI, 1356549331, was assigned on July 11, 2007. Dr. Wang graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005. Dr. Wang holds California license A98434.

Dr. Wang's primary practice is PIH Health Whittier Hospital, at 12401 Washington Blvd, Whittier, CA 90602 in Los Angeles County. The practice phone is (562) 698-0811.

Dr. Wang's primary practice is PIH Health Whittier Hospital in Whittier, California, part of PIH Health. Dr. Wang is also affiliated with PIH Health Downey Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Wang to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is board certified in hematology by the American Board of Internal Medicine. Dr. Wang is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Wang treats.

CMS data shows 5,197 Medicare services from Dr. Wang across 17 procedure codes in 2024, for 344 Medicare patients. Medicare paid $168,210 for them.

CMS counts 344 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 70, with 79% women.

In 2024, Dr. Wang wrote 1,877 Medicare Part D claims for 424 patients. 76% of them were for generic drugs. CMS names the drug for 1,557 of them, across 37 drugs with 11 or more claims each, at $1,443,248 in total drug cost. In 2023, CMS named 1,706 claims across 37 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 2 papers to Dr. Wang in 2022. Dr. Wang's most frequent co-authors are Matthew S. Block, MD, PhD, David Brooks, MD and Linda R. Duska, MD.

Dmand AI links Dr. Wang to 17 clinical trials, 7 of them phase 3 studies. 12 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 7. Open Payments lists research payments to Dr. Wang that name 3 trials.

CMS Open Payments shows 92 general payments to Dr. Wang from 30 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $429. It also lists 4 research payments totaling $3,474 from 2021 to 2023, naming 3 clinical trials.

Dr. Wang graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2005. Dr. Wang is a member of ASCO and ASH.

Dr. Wang is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.